|
Volumn 75, Issue 2, 1995, Pages 495-502
|
Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine
a a a a a a a a |
Author keywords
antibody; cancer; immunotherapy; melanoma; survival; vaccine
|
Indexed keywords
MELANOMA VACCINE;
ADULT;
ANTIBODY PRODUCTION;
ANTIBODY RESPONSE;
ARTICLE;
CANCER IMMUNOTHERAPY;
CANCER REGRESSION;
CANCER STAGING;
CLINICAL TRIAL;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRADERMAL DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MALE;
MELANOMA;
PREDICTION;
PRIORITY JOURNAL;
URTICARIA;
VACCINATION;
ANTIBODY FORMATION;
ANTIGENS, NEOPLASM;
FEMALE;
HUMAN;
MALE;
MELANOMA;
PROGNOSIS;
SKIN NEOPLASMS;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
VACCINATION;
|
EID: 0028870490
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19950115)75:2<495::AID-CNCR2820750212>3.0.CO;2-S Document Type: Article |
Times cited : (64)
|
References (23)
|